Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1773, Issue 6, 2007, Pages 903-911

  Yang, Shihe ^a   Zhou, Qiong ^a   Yang, Xiaohe ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Breast cancer; Caspase 3; Genistein; MCF 7; MDA MB 231

Indexed keywords

CASPASE 10; CASPASE 3; CASPASE 4; GENISTEIN;

APOPTOSIS; ARTICLE; BREAST CANCER; CELL DIFFERENTIATION; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; ENZYME ANALYSIS; ENZYME ASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CASPASE 10; CASPASE 3; CASPASES, INITIATOR; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GENISTEIN; HUMANS; MALE; RECEPTORS, ESTROGEN;

EID: 34249722744     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2007.03.021     Document Type: Article

References (50)

1. Messina M.J., Persky V., Setchell K.D., and Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 21 (1994) 113-131
2. Lamartiniere C.A. Protection against breast cancer with genistein: a component of soy. Am. J. Clin. Nutr. 71 (2000) 1705S-1707S (discussion 1708S-1709S)
3. Sarkar F.H., and Li Y. Mechanisms of cancer chemoprevention by soy isoflavone genistein. Cancer Metastasis Rev. 21 (2002) 265-280
4. Shao Z.M., Shen Z.Z., Fontana J.A., and Barsky S.H. Genistein's "ER-dependent and independent" actions are mediated through ER pathways in ER-positive breast carcinoma cell lines. Anticancer Res. 20 (2000) 2409-2416
5. Theodorescu D., Laderoute K.R., Calaoagan J.M., and Guilding K.M. Inhibition of human bladder cancer cell motility by genistein is dependent on epidermal growth factor receptor but not p21ras gene expression. Int. J. Cancer 78 (1998) 775-782
6. Davis J.N., Kucuk O., and Sarkar F.H. Genistein inhibits NF-kappa B activation in prostate cancer cells. Nutr. Cancer 35 (1999) 167-174
7. Suthar A.C., Banavalikar M.M., and Biyani M.K. Pharmacological activities of genistein, an isoflavone from soy (Glycine max): part I-anti-cancer activity, Indian. J. Exp. Biol. 39 (2001) 511-519
8. Barnes S. Effect of genistein on in vitro and in vivo models of cancer. J. Nutr. 125 (1995) 777S-783S
9. Dampier K., Hudson E.A., Howells L.M., Manson M.M., Walker R.A., and Gescher A. Differences between human breast cell lines in susceptibility towards growth inhibition by genistein. Br. J. Cancer 85 (2001) 618-624
10. de Lemos M.L. Effects of soy phytoestrogens genistein and daidzein on breast cancer growth. Ann. Pharmacother. 35 (2001) 1118-1121
11. Linford N.J., and Dorsa D.M. 17beta-Estradiol and the phytoestrogen genistein attenuate neuronal apoptosis induced by the endoplasmic reticulum calcium-ATPase inhibitor thapsigargin. Steroids 67 (2002) 1029-1040
12. Li Y., Upadhyay S., Bhuiyan M., and Sarkar F.H. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene 18 (1999) 3166-3172
13. Shao Z.M., Wu J., Shen Z.Z., and Barsky S.H. Genistein inhibits both constitutive and EGF-stimulated invasion in ER-negative human breast carcinoma cell lines. Anticancer Res. 18 (1998) 1435-1439
14. Wang T.T., Sathyamoorthy N., and Phang J.M. Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis 17 (1996) 271-275
15. Wang C., and Kurzer M.S. Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr. Cancer 28 (1997) 236-247
16. Le Bail J.C., Varnat F., Nicolas J.C., and Habrioux G. Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett. 130 (1998) 209-216
17. Hsieh C.Y., Santell R.C., Haslam S.Z., and Helferich W.G. Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 58 (1998) 3833-3838
18. Lim H.A., Kim J.H., Sung M.K., Kim M.K., Park J.H., and Kim J.S. Genistein induces glucose-regulated protein 78 in mammary tumor cells. J. Med. Food 9 (2006) 28-32
19. Po L.S., Chen Z.Y., Tsang D.S., and Leung L.K. Baicalein and genistein display differential actions on estrogen receptor (ER) transactivation and apoptosis in MCF-7 cells. Cancer Lett. 187 (2002) 33-40
20. He F.J., Wang J., Niu J.Z., and Wang J.F. The inhibiting effect of genistein on the growth of human breast cancer cells in vitro. Zhongguo Zhong Yao Za Zhi 27 (2002) 936-939
21. Shao Z., and Shen Z. Mechanism of growth inhibition by genistein of human breast carcinoma. Zhonghua Zhongliu Zazhi 21 (1999) 325-328
22. Monti E., and Sinha B.K. Antiproliferative effect of genistein and adriamycin against estrogen-dependent and-independent human breast carcinoma cell lines. Anticancer Res. 14 (1994) 1221-1226
23. Xu J., and Loo G. Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines. J. Cell. Biochem. 82 (2001) 78-88
24. Fioravanti L., Cappelletti V., Miodini P., Ronchi E., Brivio M., and Di Fronzo G. Genistein in the control of breast cancer cell growth: insights into the mechanism of action in vitro. Cancer Lett. 130 (1998) 143-152
25. Kousidou O.C., Mitropoulou T.N., Roussidis A.E., Kletsas D., Theocharis A.D., and Karamanos N.K. Genistein suppresses the invasive potential of human breast cancer cells through transcriptional regulation of metalloproteinases and their tissue inhibitors. Int. J. Oncol. 26 (2005) 1101-1109
26. Vissac-Sabatier C., Bignon Y.J., and Bernard-Gallon D.J. Effects of the phytoestrogens genistein and daidzein on BRCA2 tumor suppressor gene expression in breast cell lines. Nutr. Cancer 45 (2003) 247-255
27. Yang X., Stennicke H.R., Wang B., Green D.R., Janicke R.U., Srinivasan A., Seth P., Salvesen G.S., and Froelich C.J. Granzyme B mimics apical caspases. Description of a unified pathway for trans-activation of executioner caspase-3 and-7. J. Biol. Chem. 273 (1998) 34278-34283
28. Janicke R.U., Sprengart M.L., Wati M.R., and Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273 (1998) 9357-9360
29. Porter A.G., and Janicke R.U. Emerging roles of caspase-3 in apoptosis. Cell Death Differ. 6 (1999) 99-104
30. Riedl S.J., and Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat. Rev., Mol. Cell Biol. 5 (2004) 897-907
31. Miltyk W., Craciunescu C.N., Fischer L., Jeffcoat R.A., Koch M.A., Lopaczynski W., Mahoney C., Crowell J., Paglieri J., and Zeisel S.H. Lack of significant genotoxicity of purified soy isoflavones (genistein, daidzein, and glycitein) in 20 patients with prostate cancer. Am. J. Clin. Nutr. 77 (2003) 875-882
32. Nakagawa H., Yamamoto D., Kiyozuka Y., Tsuta K., Uemura Y., Hioki K., Tsutsui Y., and Tsubura A. Effects of genistein and synergistic action in combination with eicosapentaenoic acid on the growth of breast cancer cell lines. J. Cancer Res. Clin. Oncol. 126 (2000) 448-454
33. Devarajan E., Sahin A.A., Chen J.S., Krishnamurthy R.R., Aggarwal N., Brun A.M., Sapino A., Zhang F., Sharma D., Yang X.H., Tora A.D., and Mehta K. Down-regulation of caspase 3 in breast cancer: a possible mechanism for chemoresistance. Oncogene 21 (2002) 8843-8851
34. Yang X.H., Edgerton S., and Thor A.D. Reconstitution of caspase-3 sensitizes MCF-7 breast cancer cells to radiation therapy. Int. J. Oncol. 26 (2005) 1675-1680
35. Yang X.H., Sladek T.L., Liu X., Butler B.R., Froelich C.J., and Thor A.D. Reconstitution of caspase 3 sensitizes MCF-7 breast cancer cells to doxorubicin- and etoposide-induced apoptosis. Cancer Res. 61 (2001) 348-354
36. Yang X.H., and Sladek T.L. Overexpression of the E2F-1 transcription factor gene mediates cell transformation. Gene Expr. 4 (1995) 195-204
37. Miodini P., Fioravanti L., Di Fronzo G., and Cappelletti V. The two phyto-oestrogens genistein and quercetin exert different effects on oestrogen receptor function. Br. J. Cancer 80 (1999) 1150-1155
38. Smulson M.E., Simbulan-Rosenthal C.M., Boulares A.H., Yakovlev A., Stoica B., Iyer S., Luo R., Haddad B., Wang Z.Q., Pang T., Jung M., Dritschilo A., and Rosenthal D.S. Roles of poly(ADP-ribosyl)ation and PARP in apoptosis, DNA repair, genomic stability and functions of p53 and E2F-1. Adv. Enzyme Regul. 40 (2000) 183-215
39. Kumar N.B., Cantor A., Allen K., Riccardi D., and Cox C.E. The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer 94 (2002) 1166-1174
40. Hopkins-Donaldson S., Ziegler A., Kurtz S., Bigosch C., Kandioler D., Ludwig C., Zangemeister-Wittke U., and Stahel R. Silencing of death receptor and caspase-8 expression in small cell lung carcinoma cell lines and tumors by DNA methylation. Cell Death Differ. 10 (2003) 356-364
41. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M., Houtzager V.M., Nordstrom P.A., Roy S., Vaillancourt J.P., Chapman K.T., and Nicholson D.W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272 (1997) 17907-17911
42. Abu-Qare A.W., and Abou-Donia M.B. Biomarkers of apoptosis: release of cytochrome c, activation of caspase-3, induction of 8-hydroxy-2′-deoxyguanosine, increased 3-nitrotyrosine, and alteration of p53 gene. J. Toxicol. Environ. Health, B Crit. Rev. 4 (2001) 313-332
43. Fujita E., Egashira J., Urase K., Kuida K., and Momoi T. Caspase-9 processing by caspase-3 via a feedback amplification loop in vivo. Cell Death Differ. 8 (2001) 335-344
44. Liu B., Ordonez-Ercan D., Edgerton S.M., Alvarez K.M., Yang X.H., and Thor A.D. Estrogen (E2) promotes mammary tumorigenesis in MMTV-neu transgenic mice independent of MMTV activation, 97th AACR Annual Meeting, Washington DC (2006)
45. Pumford S.L., Morton M.M., Turkes A., and Griffiths K. Determination of the isoflavonoids genistein and daidzein in biological samples by gas chromatography-mass spectrometry. Ann. Clin. Biochem. 39 (2002) 281-292
46. Li Y., Ahmed F., Ali S., Philip P.A., Kucuk O., and Sarkar F.H. Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells. Cancer Res. 65 (2005) 6934-6942
47. Nahle Z., Polakoff J., Davuluri R.V., McCurrach M.E., Jacobson M.D., Narita M., Zhang M.Q., Lazebnik Y., Bar-Sagi D., and Lowe S.W. Direct coupling of the cell cycle and cell death machinery by E2F. Nat. Cell Biol. 4 (2002) 859-864
48. Hopkins-Donaldson S., Bodmer J.L., Bourloud K.B., Brognara C.B., Tschopp J., and Gross N. Loss of caspase-8 expression in highly malignant human neuroblastoma cells correlates with resistance to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis. Cancer Res. 60 (2000) 4315-4319
49. Suzuki K., Koike H., Matsui H., Ono Y., Hasumi M., Nakazato H., Okugi H., Sekine Y., Oki K., Ito K., Yamamoto T., Fukabori Y., Kurokawa K., and Yamanaka H. Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3. Int. J. Cancer 99 (2002) 846-852
50. Furukawa Y., Nishimura N., Satoh M., Endo H., Iwase S., Yamada H., Matsuda M., Kano Y., and Nakamura M. Apaf-1 is a mediator of E2F-1-induced apoptosis. J. Biol. Chem. 277 (2002) 39760-39768